SecSonar.com

iSpecimen Inc. (ISPC)

iSpecimen Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

iSpecimen Inc. (ISPC) is a Medical - Diagnostics & Research company based in US with a market capitalization of $437K. Revenue declined 79.2% year-over-year and free cash flow was negative at -$4.2M. This page tracks ISPC's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 24 employees · IPO Jun 17, 2021

Valuation

Valuation & price

$4.15 · as of May 17, 2026 · -94.7% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.14

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$77.60$40.06$2.52Jul 25Dec 25Jul 26Jul 7, 25$38.40Jul 9, 25$41.60Jul 11, 25$42.00Jul 15, 25$43.20Jul 17, 25$41.20Jul 21, 25$41.20Jul 23, 25$44.80Jul 25, 25$42.80Jul 29, 25$42.40Jul 31, 25$49.60Aug 4, 25$60.40Aug 6, 25$67.60Aug 11, 25$45.20Aug 13, 25$46.40Aug 15, 25$47.20Aug 19, 25$44.40Aug 21, 25$32.44Aug 25, 25$32.92Aug 27, 25$29.61Aug 29, 25$28.45Sep 3, 25$26.86Sep 5, 25$34.14Sep 9, 25$77.60Sep 11, 25$52.80Sep 16, 25$67.60Sep 18, 25$62.00Sep 22, 25$65.60Sep 24, 25$57.20Sep 26, 25$46.80Sep 30, 25$51.60Oct 2, 25$51.20Oct 6, 25$44.40Oct 8, 25$39.83Oct 10, 25$34.75Oct 14, 25$32.36Oct 16, 25$32.32Oct 21, 25$32.95Oct 23, 25$30.67Oct 27, 25$33.38Oct 29, 25$32.11Oct 31, 25$31.20Nov 4, 25$26.04Nov 6, 25$25.52Nov 10, 25$25.76Nov 12, 25$25.40Nov 14, 25$25.10Nov 18, 25$22.17Nov 20, 25$16.84Nov 25, 25$19.16Nov 28, 25$16.80Dec 2, 25$16.61Dec 4, 25$19.44Dec 8, 25$19.20Dec 10, 25$19.80Dec 12, 25$17.90Dec 16, 25$16.34Dec 18, 25$15.51Dec 22, 25$14.88Dec 24, 25$15.50Dec 29, 25$13.62Jan 2, 26$11.44Jan 6, 26$12.40Jan 8, 26$12.80Jan 12, 26$12.38Jan 14, 26$13.21Jan 16, 26$15.25Jan 21, 26$12.68Jan 23, 26$15.35Jan 27, 26$13.48Jan 29, 26$13.16Feb 2, 26$13.64Feb 4, 26$13.91Feb 9, 26$13.14Feb 11, 26$12.39Feb 13, 26$12.12Feb 18, 26$12.40Feb 20, 26$11.17Feb 24, 26$10.28Feb 26, 26$11.00Mar 2, 26$10.40Mar 4, 26$10.21Mar 6, 26$9.95Mar 10, 26$10.00Mar 12, 26$8.96Mar 17, 26$8.86Mar 19, 26$7.96Mar 23, 26$7.21Mar 25, 26$6.24Mar 27, 26$5.84Mar 31, 26$6.28Apr 2, 26$5.69Apr 7, 26$5.76Apr 9, 26$5.20Apr 13, 26$4.64Apr 15, 26$4.47Apr 17, 26$5.46Apr 22, 26$6.04Apr 24, 26$5.22Apr 28, 26$4.56Apr 30, 26$5.23May 4, 26$5.40May 6, 26$5.82May 8, 26$5.12May 12, 26$4.54May 14, 26$3.97May 18, 26$3.93May 20, 26$3.40May 22, 26$3.45May 28, 26$3.32Jun 1, 26$3.34Jun 3, 26$3.00Jun 5, 26$3.02Jun 9, 26$2.92Jun 11, 26$2.75Jun 15, 26$2.83Jun 17, 26$2.55Jun 22, 26$2.52Jun 24, 26$2.68Jun 26, 26$2.67Jul 2, 26$2.64
$2.5252-week range$78.00
Loading valuation history…

Fundamentals

Key fundamentals

$437K

Market cap

-79.2%

Revenue growth (YoY)

1.3%

Gross margin

-$4.2M

Free cash flow (USD)

-$6.6M

Net debt

Net cash position

547.5%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2018 → 2025

FY 2018$4.4MFY 2019$4.3MFY 2020$8.2MFY 2021$11.1MFY 2022$10.4MFY 2023$9.9MFY 2024$9.3MFY 2025$1.9M
$4.4M$1.9M

Free cash flow by year

2018 → 2025

FY 2018$-3.7MFY 2019$-4.2MFY 2020$-1.4MFY 2021$-11.7MFY 2022$-9.0MFY 2023$-10.6MFY 2024$-8.3MFY 2025$-4.2M
-$3.7M-$4.2M

Gross margin by year

2021 → 2025

FY 202152.9%FY 202254.3%FY 202351.5%FY 202442.9%FY 20251.3%
52.9%1.3%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: May 15, 2026 (EPS $-6.66)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • FinancingSecurities RegistrationJun 4, 2026Filing
  • 8-K eventDelisting NoticeJun 1, 2026Filing
  • 8-K eventAnnual Meeting ResultsMay 29, 2026Filing
  • Quarterly report10-Q FiledMay 18, 2026Filing
  • 8-K eventSecurities Purchase AgreementMay 13, 2026Filing
  • 8-K eventAmended Certificate of IncorporationMay 1, 2026Filing
  • 8-K eventAnnual Meeting AdjournedApr 13, 2026Filing
  • 8-K eventShipping Model UpdateApr 10, 2026Filing
  • Annual report10-K FiledApr 1, 2026Filing

Questions

Frequently asked questions

What is iSpecimen Inc.'s market cap?

iSpecimen Inc. (ISPC) has a market capitalization of $437K.

What is ISPC's P/E ratio?

A meaningful P/E ratio is not available for ISPC — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is ISPC's price-to-book (P/B) ratio?

ISPC trades at 0.14 times book value per share.

When did iSpecimen Inc. last report earnings?

ISPC last reported earnings on May 15, 2026; the next date is not yet scheduled.

Are insiders buying ISPC stock?

SEC Form 4 filings show no open-market insider buys at iSpecimen Inc. in the last 90 days (0 sells).

Same arena

Related companies in Medical - Diagnostics & Research

INBS

Intelligent Bio Solutions Inc.

$1.6M

BGLC

BioNexus Gene Lab Corp.

$4.4M

TRIB

Trinity Biotech plc

$7.4M

BIAF

bioAffinity Technologies, Inc.

$7.7M

NOTV

Inotiv, Inc.

$9.8M

VNRX

VolitionRx Limited

$15.6M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.